SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing significant momentum and investor excitement as the community anticipates critical clinical data regarding pancreatic cancer to be shared at the Digestive Disease Week conference. The stock is a primary focus for many traders who are highlighting a series of upcoming clinical milestones and trial expansions as key drivers for long-term growth.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense market activity following a blowout earnings report and the announcement of a multi-billion dollar share buyback, which has sparked a battle between investors capitalizing on the companys massive growth in AI-driven NAND storage demand and those taking profits after a significant year-long rally. While some traders are expressing frustration over the volatile price action and sell-the-news dynamics, the community remains heavily focused on the company's structural pricing power and long-term supply agreements as indicators of sustained value.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to a combination of a significant pipeline update regarding its CUE-401 autoimmune candidate and a fresh milestone payment from its partnership with Boehringer Ingelheim. The community is actively debating the company's long-term pivot toward autoimmune therapies under new leadership, while traders weigh the impact of potential financial restructuring against the stock's recent volatility.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp. is experiencing a massive short squeeze driven by its extremely low float and high cost-to-borrow rates, sparking intense community speculation about potential triple-digit price levels. Investors are actively debating whether this movement is a sustainable pivot toward telecommunications infrastructure or a classic high-risk pump-and-dump scenario.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is experiencing intense selling pressure following a disappointing quarterly report that featured lowered forward bookings guidance and engagement concerns, leaving the community deeply divided over its long-term viability. While some investors are aggressively buying the dip, citing user growth potential and strong cash flow, critics are actively shorting the stock, citing ongoing regulatory scrutiny regarding child safety and lackluster profitability.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following a significant earnings beat that surpassed top and bottom-line expectations, fueling community debate over the company's long-term monetization potential through AI data licensing. Investors and traders are actively discussing the stock's high growth trajectory and the potential for a short squeeze as they weigh these strong financials against broader market volatility.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is seeing heavy community debate following a robust quarterly report that featured record revenue and a massive share buyback, even as some investors question the stock's valuation and the upcoming leadership transition to John Ternus. Traders are actively analyzing the company's forward guidance and the potential impact of rising memory costs on future margins.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing significant downward pressure and intense community scrutiny following the announcement of an 80 million dollar common stock and pre-funded warrant offering. Investors are actively debating the necessity of this dilution, with many expressing deep frustration over the company's capital management, leadership performance, and the threat of another potential reverse split.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is facing significant volatility as investors weigh the broader impact of global energy shocks, geopolitical tensions in the Middle East, and the looming transition in Federal Reserve leadership. The community is sharply divided, with traders closely monitoring the impact of persistently high oil prices and potential debt-to-GDP concerns on bond yields, while actively debating the timing of a potential rotation into duration as a hedge against inflation and economic uncertainty.

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

iSpecimen Inc

iSpecimen Inc. is experiencing heightened trading activity as investors speculate on a potential short squeeze, fueled by community interest in its low float status and discussions regarding potential acquisition rumors and strategic capital positioning. While the stock has seen significant volatility, active traders are closely monitoring volume spikes and technical support levels to see if the ticker can sustain momentum and overcome recent downward trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of -55.00% and +3.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Growth in Short Interest

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totaling...

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat.com reports...

Orchestra BioMed (OBIO) to Release Earnings on Wednesday

Orchestra BioMed (NASDAQ:OBIO) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-1-orchestra-biomed-holdings-inc-stock...

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold reco...

HC Wainwright Has Optimistic Outlook of OBIO Q1 Earnings

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - HC Wainwright boosted their Q1 2026 earnings per share estimates for Orchestra BioMed in a report released on Monday, March 16th. HC...

Orchestra BioMed (NASDAQ:OBIO) Insider Purchases 10,000 Shares

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David Hochman acquired 10,000 shares of Orchestra BioMed stock in a transaction that occurred on Friday, March 13th. The stock...

Orchestra BioMed (NASDAQ:OBIO) Raised to Hold at Wall Street Zen

Wall Street Zen raised shares of Orchestra BioMed from a "strong sell" rating to a "hold" rating in a research report on Saturday...

Orchestra BioMed (NASDAQ:OBIO) Receives "Buy" Rating from Chardan Capital

Chardan Capital reiterated a "buy" rating and set a $20.00 target price on shares of Orchestra BioMed in a research report on Thursday...

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of +168.87% and +3,813.54%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded by David P. Hochman on May 25, 2020 and is headquartered in New Hope, PA.

OBIO
Orchestra BioMed Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OBIO News

OBIOOrchestra BioMed Holdings Inc